Cumberland Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Cumberland Pharmaceuticals
CPIX Stock  USD 4.72  0.07  1.51%   
Cumberland Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cumberland Pharmaceuticals' valuation are provided below:
Gross Profit
34.9 M
Profit Margin
(0.08)
Market Capitalization
69.6 M
Enterprise Value Revenue
1.5647
Revenue
41.3 M
We have found one hundred twenty available fundamental signals for Cumberland Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cumberland Pharmaceuticals prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 36.4 M in 2026. Enterprise Value is likely to drop to about 39.3 M in 2026

Cumberland Pharmaceuticals Total Revenue

39.91 Million

Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 294.7 K or Selling General Administrative of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0 or PTB Ratio of 1.59. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Cumberland Stock
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Cumberland Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets87.8 M86.9 M87.6 M
Pretty Stable
Short and Long Term Debt Total12.6 M23.7 M11.9 M
Slightly volatile
Total Current Liabilities38.2 M36.4 M20.2 M
Slightly volatile
Total Stockholder Equity25 M26.3 M52.1 M
Slightly volatile
Property Plant And Equipment Net7.8 M7.4 M2.9 M
Slightly volatile
Current Deferred Revenue6.6 M6.3 M5.3 M
Slightly volatile
Accounts Payable16.8 M16 M8.6 M
Slightly volatile
Cash26.7 M16.2 M31.5 M
Slightly volatile
Non Current Assets Total28.3 M45 M30.9 M
Slightly volatile
Cash And Short Term Investments30.2 M16.2 M37 M
Slightly volatile
Net Receivables7.6 M13.5 M8.1 M
Slightly volatile
Common Stock Shares Outstanding13.4 M12.7 M16 M
Slightly volatile
Liabilities And Stockholders Equity87.8 M86.9 M87.6 M
Pretty Stable
Non Current Liabilities Total13.6 M24.6 M14.8 M
Slightly volatile
Inventory7.2 M4.6 M7.4 M
Pretty Stable
Other Current Assets3 M3.2 M3.1 M
Very volatile
Total Liabilities31.3 M61 M33.8 M
Slightly volatile
Property Plant And Equipment Gross10.7 M10.2 M3.5 M
Slightly volatile
Total Current Assets59.5 M41.9 M56.7 M
Slightly volatile
Short Term Debt5.2 M4.9 M2.6 M
Slightly volatile
Intangible Assets15.4 M16.2 M5.8 B
Slightly volatile
Non Currrent Assets Other16.7 M15.9 M7.7 M
Slightly volatile
Other Liabilities9.2 M8.7 M5 M
Slightly volatile
Other Assets91.3 T86.9 T19.4 T
Slightly volatile
Common Stock40 M42.1 M51 M
Slightly volatile
Property Plant Equipment6.6 M6.3 M3.9 M
Slightly volatile
Net Tangible Assets4.1 M4.3 M35.3 M
Slightly volatile
Common Stock Total Equity46.2 M44.2 M54.9 M
Slightly volatile
Long Term Debt Total10.8 M17.2 M10.3 M
Slightly volatile
Non Current Liabilities Other273.1 K287.5 K2.7 M
Pretty Stable
Deferred Long Term Asset Charges18.6 K19.6 K426.2 K
Slightly volatile
Short and Long Term Debt5 M5.9 M3.6 M
Slightly volatile
Net Invested Capital47.4 M34.3 M63.2 M
Slightly volatile
Net Working Capital4.1 M4.3 M32.6 M
Slightly volatile
Capital Stock38.9 M42.1 M48.8 M
Slightly volatile
Capital Lease Obligations4 M6.1 M3.5 M
Slightly volatile

Cumberland Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization7.3 M6.9 M3.7 M
Slightly volatile
Interest Expense294.7 K545 K260.9 K
Slightly volatile
Selling General Administrative9.1 M12.8 M9.4 M
Slightly volatile
Selling And Marketing Expenses17.5 M19.6 M16.5 M
Slightly volatile
Total Revenue39.9 M43.5 M37.6 M
Pretty Stable
Gross Profit33.9 M36 M31.3 M
Pretty Stable
Other Operating Expenses40.4 M50.9 M40.3 M
Slightly volatile
Research Development5.2 M5.5 M5 M
Slightly volatile
Cost Of Revenue6 M7.6 M6.3 M
Slightly volatile
Total Operating Expenses34.4 M43.4 M33.9 M
Slightly volatile
Non Operating Income Net Other82.3 K86.6 K192.6 K
Slightly volatile
Interest Income178.6 K301 K199.4 K
Pretty Stable
Discontinued Operations2.4 M1.8 M2.8 M
Slightly volatile
Reconciled Depreciation4.8 M6.9 M3.8 M
Slightly volatile
Extraordinary Items80 K90 K98.2 K
Slightly volatile

Cumberland Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow35.7 M21.1 M34.9 M
Slightly volatile
Depreciation7.3 M6.9 M3.6 M
Slightly volatile
Capital Expenditures153.7 K161.7 K1.8 M
Slightly volatile
End Period Cash Flow26.7 M16.2 M31.5 M
Slightly volatile
Stock Based Compensation329.8 K347.2 K726.4 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.961.012.6271
Slightly volatile
PTB Ratio1.591.682.7563
Slightly volatile
Days Sales Outstanding57.1210277.9792
Slightly volatile
Book Value Per Share2.541.443.1885
Slightly volatile
Average Payables13.2 M12.6 M9.2 M
Slightly volatile
Stock Based Compensation To Revenue0.00680.00720.019
Pretty Stable
Capex To Depreciation0.03250.03421.2859
Slightly volatile
PB Ratio1.591.682.7563
Slightly volatile
EV To Sales1.041.092.1204
Slightly volatile
Inventory Turnover1.331.891.059
Slightly volatile
Days Of Inventory On Hand325200412
Pretty Stable
Payables Turnover0.520.541.1285
Slightly volatile
Sales General And Administrative To Revenue0.180.260.2469
Slightly volatile
Average Inventory5.9 M3.9 M7.5 M
Pretty Stable
Research And Ddevelopement To Revenue0.10.110.1306
Pretty Stable
Capex To Revenue0.00520.00550.05
Slightly volatile
Cash Per Share2.551.472.2831
Slightly volatile
Days Payables Outstanding729694469
Slightly volatile
Intangibles To Total Assets0.180.220.2209
Slightly volatile
Current Ratio1.261.334.156
Slightly volatile
Tangible Book Value Per Share0.280.31.816
Slightly volatile
Receivables Turnover6.563.725.1206
Slightly volatile
Shareholders Equity Per Share2.551.463.1993
Slightly volatile
Debt To Equity0.850.810.3385
Slightly volatile
Capex Per Share0.0140.01470.1084
Slightly volatile
Average Receivables6 M10.3 M7.9 M
Slightly volatile
Revenue Per Share1.932.422.2997
Slightly volatile
Interest Debt Per Share1.421.360.8062
Slightly volatile
Debt To Assets0.260.240.1367
Slightly volatile
Graham Number3.031.922.7048
Slightly volatile
Operating Cycle383301490
Pretty Stable
Price Book Value Ratio1.591.682.7563
Slightly volatile
Days Of Payables Outstanding729694469
Slightly volatile
Company Equity Multiplier3.132.981.9396
Slightly volatile
Long Term Debt To Capitalization0.140.280.1745
Slightly volatile
Total Debt To Capitalization0.450.430.2132
Slightly volatile
Debt Equity Ratio0.850.810.3385
Slightly volatile
Quick Ratio1.121.183.7306
Slightly volatile
Net Income Per E B T1.031.150.9429
Very volatile
Cash Ratio0.620.652.5493
Slightly volatile
Days Of Inventory Outstanding325200412
Pretty Stable
Days Of Sales Outstanding57.1210277.9792
Slightly volatile
Price To Book Ratio1.591.682.7563
Slightly volatile
Fixed Asset Turnover6.416.7532.5359
Slightly volatile
Debt Ratio0.260.240.1367
Slightly volatile
Price Sales Ratio0.961.012.6271
Slightly volatile
Asset Turnover0.580.5010.4762
Pretty Stable
Gross Profit Margin0.940.950.8471
Pretty Stable
Price Fair Value1.591.682.7563
Slightly volatile

Cumberland Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap36.4 M38.3 M78.3 M
Slightly volatile
Enterprise Value39.3 M41.3 M59.3 M
Slightly volatile

Cumberland Fundamental Market Drivers

Cumberland Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.3 M6.6 M
Total Revenue43.5 M39.9 M
Cost Of Revenue7.6 M6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.26  0.18 
Research And Ddevelopement To Revenue 0.11  0.10 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.42  1.93 
Ebit Per Revenue(0.20)(0.19)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY